Skip to main content
. 2020 Jan 16;69(4):501–512. doi: 10.1007/s00262-020-02482-2

Fig. 6.

Fig. 6

Obinutuzumab-experienced NK cells exhibit γc cytokine hyperresponsiveness. CD16-dependent miR-155 promotes SHIP-1 downregulation which in turn potentiates the PI3K/mTOR pathway responsible for enhanced IFN-γ translation